About imd BIOTECH GmbH

The startup has developed a biotechnology platform that utilizes advanced sensors for the detection and measurement of biomolecules, providing quantitative data with high specificity and sensitivity. This technology enables early disease detection and rapid diagnostics in emergency situations, facilitating timely medical intervention.

```xml <problem> Current food safety testing methods often require lengthy turnaround times, delaying the identification of pathogens and potentially increasing the risk of foodborne illnesses. Traditional testing methods may also lack the accuracy and ease of use needed for rapid deployment in various settings. </problem> <solution> imd BIOTECH's raPPid platform offers a solution for rapid pathogen identification through its universal technology platform. The platform combines pathogen-specific biosensors, automated analyzer hardware, and continuous measurement software to deliver faster and more accurate results. raPPid aims to address the critical requirements of Quality Managers by providing tests with turnaround times of less than 24 hours. The platform's features enable faster and accurate testing in food & feed safety, veterinary care, and healthcare settings. </solution> <features> - Pathogen-specific biosensors for targeted detection - Automated analyzer hardware for streamlined processing - Continuous measurement software for real-time data acquisition - Rapid turnaround times of less than 24 hours - High accuracy in pathogen identification - Application in food & feed safety for detecting pathogenic bacteria - Application in veterinary care for biomarker measurement - Potential application in healthcare for point-of-care diagnostics </features> <target_audience> The primary target audience includes quality managers in the food industry, veterinary professionals, and healthcare providers seeking rapid and accurate diagnostic solutions. </target_audience> ```

What does imd BIOTECH GmbH do?

Where is imd BIOTECH GmbH located?

imd BIOTECH GmbH is based in Vienna, Austria.

When was imd BIOTECH GmbH founded?

imd BIOTECH GmbH was founded in 2021.

How much funding has imd BIOTECH GmbH raised?

imd BIOTECH GmbH has raised 430000.

Location

Vienna, Austria

Founded

2021

Funding

430000

Employees

13 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

imd BIOTECH GmbH

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

imdbiotech.com 100+

Founded 2021 – Vienna, Austria

Funding

Estimated Funding

$300K+

Team (10+)

No team information available.

Company Description

Problem

Current food safety testing methods often require lengthy turnaround times, delaying the identification of pathogens and potentially increasing the risk of foodborne illnesses. Traditional testing methods may also lack the accuracy and ease of use needed for rapid deployment in various settings.

Solution

imd BIOTECH's raPPid platform offers a solution for rapid pathogen identification through its universal technology platform. The platform combines pathogen-specific biosensors, automated analyzer hardware, and continuous measurement software to deliver faster and more accurate results. raPPid aims to address the critical requirements of Quality Managers by providing tests with turnaround times of less than 24 hours. The platform's features enable faster and accurate testing in food & feed safety, veterinary care, and healthcare settings.

Features

Pathogen-specific biosensors for targeted detection

Automated analyzer hardware for streamlined processing

Continuous measurement software for real-time data acquisition

Rapid turnaround times of less than 24 hours

High accuracy in pathogen identification

Application in food & feed safety for detecting pathogenic bacteria

Application in veterinary care for biomarker measurement

Potential application in healthcare for point-of-care diagnostics

Target Audience

The primary target audience includes quality managers in the food industry, veterinary professionals, and healthcare providers seeking rapid and accurate diagnostic solutions.